Delivery Order AIDGHSI000700013-AIDOAATO1100059

This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...

This is a $9,468,085.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sanaria Inc., a for-profit, veteran-owned business, for the Phase II development of a malaria vaccine. The contract, which is not set aside, is focused on the continued research, development, and manufacturing of Sanaria's investigational Plasmodium falciparum sporozoite (PfSPZ) vaccine. This includes process improvements, non-clinical studies, and clinical trials in the U.S.,...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $64,000.00 firm fixed price purchase order contract to Sanaria Inc., a biotechnology company that specializes in malaria vaccine development. The contract is for the procurement of Sanaria's PfSPZ Reagent biological kits, which will be used for ongoing clinical trial experiments at the Laboratory of Immunogenetics (LIG) to study immune interactions with peripheral blood...

This $303,590.36 firm fixed price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Sanaria Inc., a for-profit organization and veteran-owned business that manufactures goods. The contract is for a 24-month malaria culture service to provide asexual malaria blood stage cultures and enriched late-stage gametocyte cultures to support malaria drug development efforts. This award is not associated...

This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...

The Department of State Bureau of South and Central Asian Affairs awarded a $34,500 firm fixed price purchase order to Miscellaneous Foreign Awardees - doing business as Federal Egov IAE Initiative - Generic Entity Identifier for SM-11692935-ICASS: HU - ANTIMALARIA MEDICINES (MALARONE). The prime contractor will deliver antimalaria medicines, specifically Malarone, to support the Bureau's programs in India. Performance will take place in India from July 27, 2023 through September 30, 2023. No...

<p>This is a firm fixed-price purchase order for the delivery of MALARONE anti-malaria medication from Nairobi, Kenya. The $74,087 contract was awarded by the Bureau of African Affairs, a civilian agency within the U.S. Department of State, to Miscellaneous Foreign Awardees, a for-profit organization, with a period of performance ending on December 25, 2024. The contract is not designated as a set-aside. No subcontractors are mentioned in the information provided.</p>

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Sanofi Pasteur Biologics, LLC, a foreign-owned for-profit organization. The contract is for the development and testing of a modified vaccinia Ankara (MVA) vaccine, with a ceiling value of $12,667,339.96. The contract is a definitive, cost-plus-fixed-fee contract type, with a final completion date of January 8, 2007. The...